Strategic Partnerships Entia already collaborates with large global oncology centers, indicating a prime path to expand through channel partners and benefit from joint deployments of remote monitoring solutions.

At-Home Diagnostics The world’s first at-home full blood count analyser represents a unique selling point that can be leveraged to win customers seeking non-invasive, convenient patient monitoring and reduced in-clinic visits.

Scale Opportunities With 11-50 employees and a $36M funding round, Entia is positioned to scale its remote monitoring platform; engaging hospitals or payers aiming to reduce admissions and treatment interruptions could drive substantial contract value.

Data & Tech Stack includes cloud, analytics, and ERP tools (Google Cloud, PostgreSQL, NetSuite, Kafka); opportunities exist to offer integrated data streams, analytics, or interoperability services to oncology centers and life sciences partners.

Growth Signals Healthcare market trends favor remote monitoring and personalized oncology care; Entia’s solution aligns with payer and provider incentives to improve treatment adherence and outcomes, suggesting upsell to expanded therapy programs and risk-based contracts.